
doi: 10.1042/bst0300751
pmid: 12196186
The successful design of orally active non-toxic selective metal chelators is a much sought-after goal. In order to identify an ideal chelator for clinical use, a range of specifications must be considered, such as metal selectivity and affinity, kinetic stability of the complex, bioavailability and toxicity. In this overview the comparative properties of ligands capable of endowing complexes with such properties will be discussed.
Molecular Weight, Drug Design, Biological Availability, Humans, Thermodynamics, Tissue Distribution, 540, Iron Chelating Agents, Ligands, Chelating Agents
Molecular Weight, Drug Design, Biological Availability, Humans, Thermodynamics, Tissue Distribution, 540, Iron Chelating Agents, Ligands, Chelating Agents
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 14 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
